These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29998863)

  • 41. Safety and efficacy of fixed-dose 10 mg daily isotretinoin treatment for acne vulgaris in Malaysia.
    Yap FB
    J Cosmet Dermatol; 2017 Sep; 16(3):348-352. PubMed ID: 27539948
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The results and side effects of systemic isotretinoin treatment in 100 patients with acne vulgaris.
    Kaymak Y; Ilter N
    Dermatol Nurs; 2006 Dec; 18(6):576-80. PubMed ID: 17286159
    [No Abstract]   [Full Text] [Related]  

  • 43. Thread epilation: a less traumatic technique for patients undergoing isotretinoin therapy.
    Wu S; Bhandari R; Burkhart CN
    Pediatr Dermatol; 2015; 32(1):158-9. PubMed ID: 25556964
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emergency Contraception for Patients Taking Isotretinoin.
    Gold S; Horvath S; Zaenglein A
    JAMA Dermatol; 2024 May; 160(5):487-488. PubMed ID: 38568679
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Isotretinoin treatment in patients with acne vulgaris: does it impact muscle strength, fatigue, and endurance?
    Yıldızgören MT; Rifaioğlu EN; Demirkapı M; Ekiz T; Micooğulları A; Şen T; Turhanoğlu AD
    Cutis; 2015 Jul; 96(1):33-6. PubMed ID: 26244352
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Isotretinoin for acne and rosacea.
    Watson KD; Miest RY; Tollefson MM
    Semin Cutan Med Surg; 2016 Jun; 35(2):79-86. PubMed ID: 27416313
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and adverse events of oral isotretinoin for acne: a systematic review.
    Vallerand IA; Lewinson RT; Farris MS; Sibley CD; Ramien ML; Bulloch AGM; Patten SB
    Br J Dermatol; 2018 Jan; 178(1):76-85. PubMed ID: 28542914
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Laser Safety in Isotretinoin Use: A Survey of Expert Opinion and Practice.
    Prather HB; Alam M; Poon E; Arndt KA; Dover JS
    Dermatol Surg; 2017 Mar; 43(3):357-363. PubMed ID: 28005622
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of continuous high versus low dose oral isotretinoin regimens on dermcidin expression in patients with moderate to severe acne vulgaris.
    El Aziz Ragab MA; Omar SS; Collier A; El-Wafa RAHA; Gomaa N
    Dermatol Ther; 2018 Nov; 31(6):e12715. PubMed ID: 30397984
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral isotretinoin for acne, adjusting treatment according to patient's response.
    Ghaffarpour G; Mazloomi S; Soltani-Arabshahi R; Seyed KS
    J Drugs Dermatol; 2006 Oct; 5(9):878-82. PubMed ID: 17039654
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical relevance of skin barrier changes associated with the use of oral isotretinoin: the importance of barrier repair therapy in patient management.
    Del Rosso JQ
    J Drugs Dermatol; 2013 Jun; 12(6):626-31. PubMed ID: 23839177
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reducing the oral isotretinoin skin side effects: efficacy of 8% omega-ceramides, hydrophilic sugars, 5% niacinamide cream compound in acne patients.
    Cannizzaro MV; Dattola A; Garofalo V; Del Duca E; Bianchi L
    G Ital Dermatol Venereol; 2018 Apr; 153(2):161-164. PubMed ID: 29564872
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Systematic Review on Oral Isotretinoin Therapy and Clinically Observable Wound Healing in Acne Patients.
    McDonald KA; Shelley AJ; Alavi A
    J Cutan Med Surg; 2017; 21(4):325-333. PubMed ID: 28362520
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
    Marazzi P; Boorman GC; Donald AE; Davies HD
    J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of blue light in treatment of acne.
    Bagherani N
    Dermatol Ther; 2016 May; 29(3):210. PubMed ID: 26335456
    [No Abstract]   [Full Text] [Related]  

  • 56. [Depression and panic attack in acne treated with isotretinoin].
    Alcalá Partera JA
    Semergen; 2012 Apr; 38(3):188-91. PubMed ID: 24895726
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isotretinoin: controversies, facts, and recommendations.
    Bauer LB; Ornelas JN; Elston DM; Alikhan A
    Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1435-1442. PubMed ID: 27414637
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the efficacies of intermittent and continuous low-dose isotretinoin regimens in the treatment of moderate acne vulgaris.
    Boyraz N; Mustak PK
    Int J Dermatol; 2013 Oct; 52(10):1265-7. PubMed ID: 23675954
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interpretation of Biochemical Tests Using the Reference Change Value in Monitoring Adverse Effects of Oral Isotretinoin in 102 Ethnic Turkish Patients.
    Bugdayci G; Polat M; Oguzman H; Cinpolat HY
    Lab Med; 2016 Aug; 47(3):213-9. PubMed ID: 27346869
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life.
    Cyrulnik AA; Viola KV; Gewirtzman AJ; Cohen SR
    Int J Dermatol; 2012 Sep; 51(9):1123-30. PubMed ID: 22909370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.